379 related articles for article (PubMed ID: 6128284)
1. Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome.
Raufman JP; Collins SM; Pandol SJ; Korman LY; Collen MJ; Cornelius MJ; Feld MK; McCarthy DM; Gardner JD; Jensen RT
Gastroenterology; 1983 Jan; 84(1):108-13. PubMed ID: 6128284
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.
Jensen RT; Collen MJ; McArthur KE; Howard JM; Maton PN; Cherner JA; Gardner JD
Am J Med; 1984 Nov; 77(5B):90-105. PubMed ID: 6150641
[TBL] [Abstract][Full Text] [Related]
3. Treatment of patients with Zollinger-Ellison syndrome.
Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
[TBL] [Abstract][Full Text] [Related]
4. Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion.
Metz DC; Soffer E; Forsmark CE; Cryer B; Chey W; Bochenek W; Pisegna JR
Am J Gastroenterol; 2003 Feb; 98(2):301-7. PubMed ID: 12591045
[TBL] [Abstract][Full Text] [Related]
5. Laparotomy and proximal gastric vagotomy in Zollinger-Ellison syndrome: results of a 16-year prospective study.
McArthur KE; Richardson CT; Barnett CC; Eshaghi N; Smerud MJ; McClelland RN; Feldman M
Am J Gastroenterol; 1996 Jun; 91(6):1104-11. PubMed ID: 8651153
[TBL] [Abstract][Full Text] [Related]
6. Effect of vagotomy in Zollinger-Ellison syndrome.
Richardson CT; Feldman M; McClelland RN; Dickerman RM; Kumpuris D; Fordtran JS
Gastroenterology; 1979 Oct; 77(4 Pt 1):682-6. PubMed ID: 467924
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Maton PN; Gardner JD; Jensen RT
Gastroenterol Clin North Am; 1989 Dec; 18(4):847-63. PubMed ID: 2575602
[TBL] [Abstract][Full Text] [Related]
8. An open-label study of rabeprazole in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion.
Morocutti A; Merrouche M; Bjaaland T; Humphries T; Mignon M
Aliment Pharmacol Ther; 2006 Nov; 24(10):1439-44. PubMed ID: 17081164
[TBL] [Abstract][Full Text] [Related]
9. [Long-term suppression of H+ secretion through a combination of cimetidine and methanthelinbromide (author's transl)].
Scholten T; Fritsch WP; Müller JE; Hengels KJ
Dtsch Med Wochenschr; 1979 Dec; 104(52):1849-53. PubMed ID: 42523
[TBL] [Abstract][Full Text] [Related]
10. Changing concepts in the presentation, diagnosis and management of the Zollinger-Ellison syndrome.
Mee AS; Ismail S; Bornman PC; Marks IN
Q J Med; 1983; 52(206):256-67. PubMed ID: 6137024
[TBL] [Abstract][Full Text] [Related]
11. Zollinger-Ellison syndrome: presentation, response to therapy, and outcome.
Wilcox CM; Seay T; Arcury JT; Mohnen J; Hirschowitz BI
Dig Liver Dis; 2011 Jun; 43(6):439-43. PubMed ID: 21193359
[TBL] [Abstract][Full Text] [Related]
12. Medical treatment of Zollinger-Ellison syndrome with ranitidine.
Vezzadini P; Bonora G; Tomassetti P; Pazzaglia M; Labò G
Int J Tissue React; 1983; 5(4):339-43. PubMed ID: 6323334
[TBL] [Abstract][Full Text] [Related]
13. Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study.
Hirschowitz BI; Simmons J; Mohnen J
Aliment Pharmacol Ther; 2001 Nov; 15(11):1795-806. PubMed ID: 11683694
[TBL] [Abstract][Full Text] [Related]
14. Nutrient malabsorption in the Zollinger-Ellison syndrome. Normalization during long-term cimetidine therapy.
King CE; Toskes PP
Arch Intern Med; 1983 Feb; 143(2):349-51. PubMed ID: 6824402
[TBL] [Abstract][Full Text] [Related]
15. Zollinger-Ellison syndrome. Current concepts in diagnosis and management.
Wolfe MM; Jensen RT
N Engl J Med; 1987 Nov; 317(19):1200-9. PubMed ID: 3309661
[TBL] [Abstract][Full Text] [Related]
16. Gastric emptying and secretion in Zollinger-Ellison syndrome.
Dubois A; Eerdewegh PV; Gardner JD
J Clin Invest; 1977 Feb; 59(2):255-63. PubMed ID: 833274
[TBL] [Abstract][Full Text] [Related]
17. Presentation, response to lansoprazole therapy, and outcome of Zollinger-Ellison syndrome-like gastric acid hypersecretors.
Wilcox CM; Seay T; Arcury J; Hirschowitz BI
Scand J Gastroenterol; 2011 Mar; 46(3):277-80. PubMed ID: 21073392
[TBL] [Abstract][Full Text] [Related]
18. Costs and risks in the management of patients with gastric acid hypersecretion.
Hirschowitz BI; Fineberg N; Wilcox CM; Mohnen J; Worthington J
J Clin Gastroenterol; 2010 Jan; 44(1):28-33. PubMed ID: 19581810
[TBL] [Abstract][Full Text] [Related]
19. Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study.
Maton PN; Frucht H; Vinayek R; Wank SA; Gardner JD; Jensen RT
Gastroenterology; 1988 Feb; 94(2):294-9. PubMed ID: 3335308
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with histamine H2-receptor antagonists in Zollinger-Ellison syndrome.
Lamers CB; Festen HP; van Tongeren JH
Am J Gastroenterol; 1978 Sep; 70(3):286-91. PubMed ID: 717379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
